Long-term Toxicity and Survival Outcomes After Stereotactic Ablative Radiotherapy for Patients with Centrally Located Thoracic Tumors

BACKGROUND: Stereotactic ablative radiotherapy (SABR) is effective for thoracic cancer and metastases; however, adverse effects are greater for central tumors. We evaluated factors affecting outcomes and toxicities after SABR for patients with primary lung and oligometastatic tumors. PATIENTS AND ME...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Radiol Oncol
Päätekijät: Atalar, Banu, Mustafayev, Teuta Zoto, Sio, Terence T., Sahin, Bilgehan, Gungor, Gorkem, Aydın, Gokhan, Yapici, Bulent, Ozyar, Enis
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Sciendo 2020
Aiheet:
Research Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7585334/
https://ncbi.nlm.nih.gov/pubmed/32589607
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2478/raon-2020-0039
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia